TOP 5 ARTICLES FROM APRIL 2010

• Clinical Implications of the BRAVO and CRUISE Trials

  How should physicians apply this new information in their treatment of CRVO and BRVO?

  by David M. Brown, MD, FACS

• When to Treat and Not to Treat Patients With Central Serous Retinopathy

  Reduced-fluence PDT is the current accepted treatment for CSR.

  by Francesco Boscia, MD

• Fluidics in Modern Vitrectomy
• Progress Report: The MacTel Project

  At the 5-year mark of the collaboration, much has been learned, but still no treatment is available.

  by Mark C. Gillies, MB BS, PHD, FRANZCO

• Continuous-wave and Micropulse 577 nm Yellow Laser Photocoagulation: A Laser for All Reasons

  by Martin A. Mainster, PhD, MD, FRCOphth